Search Results - "Pisegna, S."

p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells by Pisegna, Simona, Pirozzi, Gianluca, Piccoli, Mario, Frati, Luigi, Santoni, Angela, Palmieri, Gabriella

“…Natural killer (NK) cells are a component of the innate immunity against viral infections through their rapid cytotoxic activity and cytokine production…”
Get full text

Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence by Caponnetto, S., Gelibter, A., Mosillo, C., Magri, V., Scagnoli, S., Pomati, G., Piesco, G., Verkhovskaya, S., Pisegna, S., Sirgiovanni, G., Napoli, V., Buscicchio, D., Iannantuono, G.M., Marinelli, D., Mammone, G., Pannunzio, S., Nicolo', E., Stefani, A., Astorino, V., Mancini, M., Cortesi, E.

Get full text

3MO Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors by Marinelli, D., Pisegna, S., Giammaruco, M., Chesi, P., Mammone, G., Ceddia, S., Gazzaniga, P., Cortesi, E., Gelibter, A.J.

Get full text

1252P Liquid biopsy to track KRAS G12C mutation at progressive disease in patients with advanced non-small cell lung cancer (NSCLC) by De Renzi, G., Nicolazzo, C., Pisegna, S., Belardinilli, F., Bottillo, I., Grammatico, P., Giannini, G., Gelibter, A.J., Gazzaniga, P.

Get full text

127P RAS, RAF and NF1 oncogenic mutations in KRAS-mutated lung adenocarcinoma by Marinelli, D., Pisegna, S., Chiavassa, A., Bengala, E., Capasso, C., Sabatini, A., Ciurluini, F., Artemi, A., Torchia, A., Gallina, F.T., Botticelli, A., Gazzaniga, P., Cortesi, E., Gelibter, A.J.

Get full text

Zinc modulates c-Myc Mad1 balance in human leukemia cells by Sirinian, M I, Pisegna, S, Paroli, M, Militi, S, Testa, U, Peschle, C

“…LEUKEMIA: (2003) 17, 272-274. doi:10.1038/sj.leu.2402746…”
Get full text

267P AB-ITALY: The impact of drug-drug interaction on abemaciclib treatment in Italian real world experience by Botticelli, A., Scagnoli, S., Pisegna, S., Toss, A., Fabi, A., Criscitiello, C., D'Auria, G., Fabbri, M.A., Orlandi, A., Barberi, V., Caputo, R., Vici, P., Palleschi, M., Santini, D., Tomasello, G., Ricevuto, E., M. Simmaco, Preissner, R., Cortesi, E., Marchetti, P.

Get full text

Association between body composition and toxicities among patients with metastatic breast cancer (BC) treated with CDK4/6 inhibitors by Imbimbo, G., Pellegrini, M., Ardovino, M., Tambaro, F., Pisegna, S., Scagnoli, S., Rizzo, V., Amabile, M.I., Muscaritoli, M., Botticelli, A., Molfino, A.

Get full text

236P Trastuzumab deruxtecan in Italian real-world experience: Updated analysis from DE-REAL study by Botticelli, A., Pisegna, S., Scagnoli, S., Santini, D., De Laurentiis, M., Caputo, R., Scafetta, R., Palleschi, M., Orlandi, A., Ballatore, Z., Giampaglia, M., Chiavassa, A., Alesini, D., Rossi, L., Fabbri, M.A., D'Auria, G., Vici, P., Strigari, L., Marchetti, P., Fabi, A.

Get full text

224P Clinical features and outcomes in HER2+ mBC patients treated with trastuzumab deruxtecan: A subgroup analysis of the De-REAL study by Botticelli, A., Scagnoli, S., Pisegna, S., Santini, D., De Laurentiis, M., Caputo, R., Verrazzo, A., Scafetta, R., Orlandi, A., Palleschi, M., Alesini, D., Barberi, V., Fabbri, M.A., D'Auria, G., Strigari, L., Ballatore, Z., Tedesco, B., Preissner, R., Marchetti, P., Fabi, A.

Get full text

Src-Dependent Syk Activation Controls CD69-Mediated Signaling and Function on Human NK Cells by Pisegna, Simona, Zingoni, Alessandra, Pirozzi, Gianluca, Cinque, Benedetta, Cifone, Maria Grazia, Morrone, Stefania, Piccoli, Mario, Frati, Luigi, Palmieri, Gabriella, Santoni, Angela

“…CD69 C-type lectin receptor represents a functional triggering molecule on activated NK cells, capable of directing their natural killing function. The…”
Get full text

Detection of Homozygous Deletions of the Cyclin-Dependent Kinase 4 Inhibitor (p16) Gene in Acute Lymphoblastic Leukemia and Association With Adverse Prognostic Features by Fizzotti, Marco, Cimino, Giuseppe, Pisegna, Simona, Alimena, Giuliana, Quartarone, Cristina, Mandelli, Franco, Pelicci, Pier Giuseppe, Coco, Francesco Lo

“…A recently described putative tumor suppressor gene, the cyclin-dependent kinase 4 inhibitor (p16), has been shown to be altered by deletions and/or point…”
Get full text

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias by Lo Coco, F, Pisegna, S, Diverio, D

“…Department of Human Biopathology, University La Sapienza of Rome, Italy. lococo@dbu.uniroma1.it BACKGROUND AND OBJECTIVE: The AML1 gene was identified in 1991…”
Get full text

Comparative Efficacy of Rabeprazole and Pantoprazole in the Control of Nocturnal Acid Output and Intragastric Acidity by Hank S. Wang, David S. Oh, Ariana Anderson, Jose Nieto, Phuong Tien, Gordon Ohning, Joseph R. Pisegna

“…Background/Aims: Nocturnal reflux is a largely undiagnosed and unmanaged condition predisposing to multiple esophageal complications. We evaluated the effects…”
Get full text

Comparative Efficacy of Rabeprazole and Pantoprazole in the Control of Nocturnal Acid Output and Intragastric Acidity by Hank S. Wang, David S. Oh, Ariana Anderson, Jose Nieto, Phuong Tien, Gordon Ohning, Joseph R. Pisegna

“…Background/Aims: Nocturnal reflux is a largely undiagnosed and unmanaged condition predisposing to multiple esophageal complications. We evaluated the effects…”
Get full text

Comparative Efficacy of Rabeprazole and Pantoprazole in the Control of Nocturnal Acid Output and Intragastric Acidity by Hank S. Wang, David S. Oh, Ariana Anderson, Jose Nieto, Phuong Tien, Gordon Ohning, Joseph R. Pisegna

“…Background/Aims: Nocturnal reflux is a largely undiagnosed and unmanaged condition predisposing to multiple esophageal complications. We evaluated the effects…”
Get full text

Comparative Efficacy of Rabeprazole and Pantoprazole in the Control of Nocturnal Acid Output and Intragastric Acidity by Hank S. Wang, David S. Oh, Ariana Anderson, Jose Nieto, Phuong Tien, Gordon Ohning, Joseph R. Pisegna

“…Background/Aims: Nocturnal reflux is a largely undiagnosed and unmanaged condition predisposing to multiple esophageal complications. We evaluated the effects…”
Get full text